pharma news today glp-1 obesity drugs Market Overview: Agonists and the Market | Blog GLP-1 Therapies Drive Indian Pharma

For more in-depth analyses and the latest updates on diabetes management, visit our Insights section

This explainer will give you a brief overview of the issues and then summarize some recent publications the benefits and costs of drugs like semaglutide and tirzepatide

It is also approved for the treatment of obstructive sleep apnoea in adults living with obesity

Nutraceutical-grade oils typically contain 1000 mg/kg or higher, with some ultra-high polyphenol varieties exceeding 2,000 mg/kg

Liraglutide effects on glycemic control and weight in patients with type 2 diabetes Mellitus: A real-world, observational study and brief narrative review

Eli Lillys Mounjaro, which is awaiting regulatory approval to treat obesity, activates receptors for GLP-1 and a similar hormone called GIP and leads to about 20% weight loss